Clinical Trial Record

Return to Clinical Trials

The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma


2017-01-01


2021-12-01


2023-01-01


87

Study Overview

The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

The aim of this study is to investigate whether the albumin value and the ratios of biochemical markers; hemoglobin, albumin, lymphocyte and platelet (HALP score) and lymphocyte-C-reactive protein ratio (LCR) can predict the survival and recurrence of the disease in patients with pancreatic adenocarcinoma.

N/A

  • Pancreatic Neoplasms
  • Pancreas Cancer
    • EUTFHALPSCOREFORPANCREAS

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2024-08-10  

    N/A  

    2024-08-10  

    2024-08-10  

    N/A  

    2024-08-14  

    2024-08-14  

    N/A  

    2024-08  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    Primary Outcome MeasuresMeasure DescriptionTime Frame
    Disease-Free Survival Times4 Years
    HALP ScoreHemoglobin x Albumin x Lymphocyte / Platelet4 Years
    Overall Survival Time4 Years
    LCR ScoreLymphocyte / CRP4 Years
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:

      Inclusion Criteria:

    • Whipple operation and total pancreatectomy due to pathologically confirmed pancreatic adenocarcinoma

    • Exclusion Criteria:

    • Patients with other malignant tumors (choledochal tumor, papilla tumor and duodenal tumor)

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available